Bulletin
Investor Alert

Rafael Holdings Inc.

NYS: RFL

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Rafael Holdings Inc.

Market closed

 --Quotes are delayed by 20 min

Mar 30, 2023, 4:10 p.m.

RFL
/zigman2/quotes/206275218/composite

$

1.60

Change

-0.05 -3.03%

Volume

Volume 124,982

Quotes are delayed by 20 min

/zigman2/quotes/206275218/composite

Previous close

$ 1.65

$ 1.60

Change

-0.05 -3.03%

Day low

Day high

$1.58

$1.65

Open

52 week low

52 week high

$1.58

$2.85

Open

Company Description

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests a...

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.

Valuation

Price to Sales Ratio

97.39

Price to Book Ratio

0.49

Enterprise Value to EBITDA

0.15

Enterprise Value to Sales

-8.17

Total Debt to Enterprise Value

-1.29

Efficiency

Revenue/Employee

17,826.00

Income Per Employee

-5,340,348.00

Receivables Turnover

0.66

Total Asset Turnover

0.00

Liquidity

Current Ratio

5.15

Quick Ratio

5.15

Cash Ratio

3.01

Profitability

Gross Margin

82.44

Operating Margin

-14,750.49

Pretax Margin

-34,139.51

Net Margin

-29,958.05

Return on Assets

-90.19

Return on Equity

-110.26

Return on Total Capital

-45.91

Return on Invested Capital

-110.26

Capital Structure

Total Debt to Total Equity

14.92

Total Debt to Total Capital

12.99

Total Debt to Total Assets

12.68

Officers and Executives

Name Age Officer Since Title
Mr. Howard S. Jonas 64 2017 Chairman & Chief Executive Officer
Mr. William Conkling - 2021 Chief Commercial Officer
Mr. David A. Polinsky 50 2017 Chief of Staff
Mr. Gus Kodersha - 2021 Chief Technical Operations Officer
Ms. Rachel Jonas - 2021 Director

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/05/2023 Stephen M. Greenberg
Director 		27,174   Award at $1.84 per share. 50,000
01/05/2023 Michael J. Weiss
Director 		27,174   Award at $1.84 per share. 50,000
01/05/2023 Boris C. Pasche
Director 		27,174   Award at $1.84 per share. 50,000
01/05/2023 Mark A. McCamish
Director 		27,174   Award at $1.84 per share. 50,000
12/21/2022 William Conkling
Chief Executive Officer 		56,149   Derivative/Non-derivative trans. at $1.76 per share. 98,822
12/21/2022 Patrick Fabbio
CFO & President 		27,928   Derivative/Non-derivative trans. at $1.76 per share. 49,153
08/09/2022 Howard S. Jonas
64,674   Disposition at $1.84 per share. 119,000
08/08/2022 Howard S. Jonas
14,787   Disposition at $1.94 per share. 28,686
08/05/2022 Howard S. Jonas
33,100   Disposition at $1.93 per share. 63,883
02/01/2022 William Conkling
Chief Executive Officer 		623,732   Award at $0 per share. 0
02/01/2022 Patrick Fabbio
CFO & President 		363,103   Award at $0 per share. 0
02/01/2022 Ameet Mallik
Director 		908,497   0
01/19/2022 Stephen M. Greenberg
Director 		7,512   Award at $5.39 per share. 40,489
01/05/2022 Boris C. Pasche
Director 		7,512   Award at $5.39 per share. 40,489
01/05/2022 Mark A. McCamish
Director 		5,412   Award at $5.39 per share. 29,170
01/05/2022 Shannon Thyme Klinger
Director 		5,412   Award at $5.39 per share. 29,170
09/23/2021 David A. Polinsky
Chief Financial Officer 		571   Derivative/Non-derivative trans. at $35.77 per share. 20,424
05/27/2021 Ameet Mallik
Director 		908,497   Award at $44.7 per share. 40,609,815
/news/latest/company/us/rfl

MarketWatch News on RFL

/news/nonmarketwatch/company/us/rfl

Other News on RFL

  1. 10-Q: RAFAEL HOLDINGS, INC.

    4:47 p.m. March 14, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-Q: RAFAEL HOLDINGS, INC.

    9:12 a.m. Dec. 13, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. 10-K: RAFAEL HOLDINGS, INC.

    4:55 p.m. Oct. 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Tracking Kahn Brothers Portfolio - Q2 2022 Update

    10:37 p.m. Aug. 11, 2022

    - Seeking Alpha

  7. 10-Q: RAFAEL HOLDINGS, INC.

    4:52 p.m. June 14, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. Tracking Kahn Brothers Portfolio - Q1 2022 Update

    8:57 p.m. May 2, 2022

    - Seeking Alpha

  13. Tracking Kahn Brothers Portfolio - Q4 2021 Update

    10:59 p.m. Jan. 25, 2022

    - Seeking Alpha

  14. Rafael announces CEO transition

    8:20 a.m. Jan. 21, 2022

    - Seeking Alpha

  16. In a Bad Year for Biotech Stocks, Deals and Vaccines Were Winners

    3:34 a.m. Dec. 16, 2021

    - The Wall Street Journal Interactive Edition

  17. Rafael Holdings: A Coin Flip

    2:28 p.m. Nov. 18, 2021

    - Seeking Alpha

  20. Tracking Kahn Brothers Portfolio - Q3 2021 Update

    1:00 a.m. Nov. 3, 2021

    - Seeking Alpha

  21. Loading more headlines...

At a Glance

Rafael Holdings, Inc.

520 Broad Street

Newark, New Jersey 07102

Phone

1 2126581450

Industry

Real Estate Developers

Sector

Real Estate/Construction

Fiscal Year-end

07/2023

View SEC Filings

Revenue

$410,000

Net Income

$-122.83M

Employees

23.00

Annual Report for RFL

/news/pressrelease/company/us/rfl

Press Releases on RFL

  8. Friday 7/8 Insider Buying Report: RFL, BRK.A

    4:22 p.m. July 8, 2022

    - MarketNewsVideo.com

Link to MarketWatch's Slice.